DBV Technologies S.A. (EPA:DBV)
2.270
-0.005 (-0.22%)
At close: Dec 5, 2025
DBV Technologies Employees
As of December 31, 2024, DBV Technologies had 110 total employees, including 109 full-time and 1 part-time employees. The number of employees increased by 5 or 4.76% compared to the previous year.
Employees
110
Change (1Y)
5
Growth (1Y)
4.76%
Revenue / Employee
€40,080
Profits / Employee
€911,546
Market Cap
407.85M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| EssilorLuxottica Société anonyme | 153,498 |
| Sanofi | 82,878 |
| Sartorius Stedim Biotech | 9,901 |
| bioMérieux | 14,754 |
| Eurofins Scientific SE | 62,696 |
| Ipsen | 5,358 |
| ABIVAX Société Anonyme | 69 |
| Virbac | 6,365 |
DBV Technologies News
- 2 days ago - DBVT: Guggenheim Initiates Coverage with 'Buy' Rating and $35 PT | DBVT Stock News - GuruFocus
- 23 days ago - DBVT Completes Key Phase 3 Trial for Peanut Allergy Treatment - GuruFocus
- 24 days ago - DBV Technologies On Track To Report Data From VITESSE Phase 3 Trial Of VIASKIN Peanut Patch In Q4 - Nasdaq
- 24 days ago - DBV Technologies Announces Last Patient Visit Completed in VITESSE Phase 3 Clinical Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years - GlobeNewsWire
- 4 weeks ago - DBV Technologies to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference - GlobeNewsWire
- 4 weeks ago - DBV Technologies Appoints Industry Leader Kevin Trapp as Chief Commercial Officer - GlobeNewsWire
- 5 weeks ago - DBV Technologies Announces Appointment of Philina Lee, Ph.D. to Board of Directors - GlobeNewsWire
- 5 weeks ago - DBV Technologies to Participate in Upcoming ACAAI 2025 Annual Scientific Meeting - GlobeNewsWire